Q BioMed Inc.

QBIOOTCHealthcare

$0.00

$-0.00(-0.00%)

Market Cap$14509

P/E Ratio—

52W High$0.02505

52W Low$0.000099999997

Avg Volume376

Open$0.00

Beta-154.93

Overview

Q BioMed Inc. (QBIO) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

QBIO · earnings · updated Jun 9, 2026

Latest Earnings

Q2 FY2023Report Date: May 26, 2023

EPS Actual

$0.08

Est. $0.04 · +100.0%

Revenue

$0.00B

Est. $0.02B · -99.9%

Fiscal Period

Q2 FY2023

FY ends December

Report Date

May 26, 2023

After Market Close

▲ Beat EPS▼ Miss Revenue✓ 2-Quarter EPS Beat Streak

QBIO reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

$-0.11

Rev. $0.17B

Days Away84

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.$-0.11

Rev. Est.$0.17B

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
◌ Q2 FY2026	Apr 29, 2026	—	—	—	—	—	—
◌ Q2 FY2026	Apr 29, 2026	-$0.10	—	—	—	$0.00B	—
◌ Q1 FY2025	Feb 21, 2025	—	—	—	—	—	—
◌ Q1 FY2025	Jan 7, 2025	—	—	—	—	—	—
◌ Q4 FY2024	Oct 28, 2024	—	—	—	—	$0.00B	—
◌ Q2 FY2024	May 31, 2024	—	—	—	—	$0.00B	—
◌ Q2 FY2024	Apr 26, 2024	—	—	—	—	$0.00B	—
◌ Q4 FY2023	Dec 1, 2023	—	—	—	—	$0.00B	—

Q2 FY2026

Apr 29, 2026

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2026

Apr 29, 2026

EPS Actual

—

EPS Est.

-$0.10

EPS Surpr.

—

Revenue

—

Q1 FY2025

Feb 21, 2025

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2025

Jan 7, 2025

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2024

Oct 28, 2024

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2024

May 31, 2024

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2024

Apr 26, 2024

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2023

Dec 1, 2023

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Analyst Estimates

Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.

EPS Estimates

Period	Low	Consensus	High	# Analysts
Q3 FY2028	$0.04	$0.04	$0.04	1
Q2 FY2028	$-0.06	$-0.06	$-0.06	1
Q1 FY2028	$-0.08	$-0.08	$-0.08	1
Q4 FY2027	$0.04	$0.04	$0.04	1
Q3 FY2027	$-0.06	$-0.06	$-0.06	1
Q2 FY2027	$-0.08	$-0.08	$-0.08	1

Revenue Estimates

Period	Low	Consensus	High	# Analysts
Q3 FY2028	$0.0B	$0.0B	$0.0B	1
Q2 FY2028	$0.0B	$0.0B	$0.0B	1
Q1 FY2028	$0.0B	$0.0B	$0.0B	1
Q4 FY2027	$0.0B	$0.0B	$0.0B	1
Q3 FY2027	$0.0B	$0.0B	$0.0B	1
Q2 FY2027	$0.0B	$0.0B	$0.0B	1

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
▲ Q2 FY2023	May 26, 2023	+100.0%	$0.01	$0.01	+2.91%
▲ Q4 FY2022	Nov 3, 2022	+50.0%	$0.02	$0.02	+21.21%

Q2 FY2023+2.91%

Report Date

May 26, 2023

EPS Beat/Miss

+100.0%

Price Before

$0.01

Price After

$0.01

Q4 FY2022+21.21%

Report Date

Nov 3, 2022

EPS Beat/Miss

+50.0%

Price Before

$0.02

Price After

$0.02

Avg Beat Reaction+12.06%

Beat Rate2 / 2 quarters

Largest Move+21.21% (Q4 FY2022)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Q BioMed Inc. (QBIO) most recently reported earnings on May 26, 2023 for Q2 FY2023, posting EPS of $0.08 — beating the analyst consensus of $0.04 by +100.0%. QBIO has beaten EPS estimates for 2 consecutive quarters. The next QBIO earnings date is expected around September 1, 2026.

Each quarter, investors track QBIO earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. QBIO revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

QBIO's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

QBIO earnings · 5 questions

Q BioMed Inc.'s next earnings report is expected around September 1, 2026. QBIO typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; QBIO historically reports after market close (AMC).

QBIO earnings datewhen is QBIO earningsQBIO next earnings datewhen does QBIO report earningsQBIO earnings calendar

▸ Source: FMP · Q BioMed Inc. SEC filings · US GAAP · Q BioMed Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026